Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Anpac Bio-Medical Science ADR (NQ: ANPC ) 4.370 UNCHANGED Last Price Updated: 3:59 PM EDT, May 19, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Anpac Bio-Medical Science ADR < Previous 1 2 Next > InvestorNewsBreaks – Fresh2 Group Ltd. (NASDAQ: ANPC) Ticker Symbol Change Part of Focus on New Business Line May 19, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – Fresh2 Group Limited (NASDAQ: ANPC) Files Q1 2023, FY 2022 Financial Report May 17, 2023 Via Investor Brand Network Topics Economy Intellectual Property Supply Chain Exposures Intellectual Property Supply Chain InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Closes on $3M Registered Direct Offering April 10, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Enters Asset Purchase Agreement with e-Commerce Food-Service Company April 04, 2023 Via Investor Brand Network Topics Intellectual Property Supply Chain Exposures Intellectual Property Supply Chain InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Enters into $3M Registered Direct Offering April 03, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct Offering March 31, 2023 From AnPac Bio-Medical Science Co., Ltd. Via GlobeNewswire InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receives Approval for Continued Listing, Granted Until July 12 to Meet Equity Rule March 23, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receive First Payment on ‘Milestone’ Purchase of Cancer Detection Equipment March 07, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces US$5M Private Placement March 06, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Reports Positive Results from Multiyear, Multicancer Follow-Up Study February 22, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Acquires GISN to Enhance Efficiency of e-Commerce Operations February 15, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Inks Acquisition Deal to Expand in the US February 13, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Signs Agreement to Acquire a B2B Asian Food E-Commerce Platform February 09, 2023 Via Investor Brand Network Topics Economy Intellectual Property Supply Chain Exposures Intellectual Property Supply Chain InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Signs $5.2M of Definitive Investment Agreements January 25, 2023 Via Investor Brand Network Topics Economy Intellectual Property Exposures Intellectual Property Supply Chain InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Releases Report Noting 48.8% Decrease in 2022 Net Loss December 20, 2022 Via Investor Brand Network Topics Intellectual Property Exposures COVID-19 Intellectual Property AnPac Announces the Plan of US$5,000,000 Private Placement December 05, 2022 From AnPac Bio-Medical Science Co., Ltd. Via GlobeNewswire AnPac Announces Strategic Initiative to Establish A Wholly-Owned Subsidiary for US Food Market December 05, 2022 From AnPac Bio-Medical Science Co., Ltd. Via GlobeNewswire InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Regains Compliance with Nasdaq Listing Requirement November 30, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property AnPac Announces Regaining Compliance with Nasdaq Listing Requirement November 30, 2022 From AnPac Bio-Medical Science Co., Ltd. Via GlobeNewswire InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Board of Directors Sees Changes November 10, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property AnPac Bio Announces Changes to the Board of Directors November 10, 2022 From AnPac Bio-Medical Science Co., Ltd. Via GlobeNewswire InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Continued Listing Status Granted by NASDAQ Hearing Panel November 04, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property AnPac Bio Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting $1 Bid Price Compliance Rule On or Before Nov. 23, 2022 November 04, 2022 From AnPac Bio-Medical Science Co., Ltd. Via GlobeNewswire InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Plans to Implement ADS Ratio Change October 18, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property AnPac Bio Announces Plan to Implement ADS Ratio Change October 18, 2022 From AnPac Bio-Medical Science Co., Ltd. Via GlobeNewswire InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Names New Board Members, Management Changes October 04, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property AnPac Bio Announces Board and Management Changes October 03, 2022 From AnPac Bio-Medical Science Co., Ltd. Via GlobeNewswire BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC), New Investor Group Sign $3.67M Equity Investment Agreements September 27, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces NASDAQ Delisting Appeal, Hearing September 19, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Names New Board Members, Co-CEO August 08, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.